术前高剂量率近距离放疗在早期宫颈癌中的作用
中位随访37.4个月,未观察到孤立阴道穹隆复发,3年局部无复发生存率98%,盆腔无复发生存率90%,总生存率97%。术前近距离放疗可实现高局部控制,减少阳性切缘和淋巴血管间隙浸润,避免辅助治疗。
要点
- 术前IGABT联合微创手术在早期宫颈癌中显示高局部控制率。
- 3年局部无复发生存率98%,盆腔无复发生存率90%,总生存率97%。
- 未观察到孤立阴道穹隆复发,仅3例(4.3%)盆腔复发。
核心结论
- 术前图像引导自适应近距离放疗后行微创手术可实现高局部控制,减少阳性手术切缘和淋巴血管间隙浸润率,避免辅助治疗。
主要发现
- 中位随访37.4个月(95%CI 32.1-39.7个月),未观察到孤立阴道穹隆复发,3例(4.3%)盆腔复发。
- 无患者接受术后放疗或放化疗。
- 3年局部无复发生存率98%(95%CI 89%-100%),盆腔无复发生存率90%(95%CI 80%-96%),无病生存率88%(95%CI 77%-94%),总生存率97%(95%CI 88%-99%)。
- 显微镜下阴道切缘阳性(R1)1例(1.4%),淋巴血管间隙浸润6例(8.6%)。
临床怎么用
- 手术方式应与患者讨论,包括将术前近距离放疗作为降期治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the clinical outcomes and the safety of preoperative high-dose-rate (HDR) image-guided adaptive brachytherapy (IGABT) followed by minimally invasive surgery (MIS) in the multidisciplinary management of early-stage cervical cancer. METHODS AND MATERIALS: Medical records of all consecutive patients with early-stage cervical cancer treated at our institution between 2012 and 2018 with preoperative IGABT in a multidisciplinary approach were reviewed. Treatment schedule was pelvic node dissection, preoperative IGABT followed 6-8 week later by MIS hysterectomy. RESULTS: Seventy patients with cervical cancer FIGO stages (IB1 18.6%, IB2 75.7% and IIA1 5.7%) were treated by preoperative HDR brachytherapy. With a median follow-up of 37.4 months [95% confidence interval, 32.1-39.7 months] isolated vaginal vault recurrence was not observed, 3 pelvic relapses were reported (4.3%). None of patients received postoperative radiotherapy (EBRT) or radiochemotherapy. The estimated 3-year local and pelvis relapse free survival for the entire population were respectively 98% [95% confidence interval, 89%-100%] and 90% [80%-96%]. The estimated 3-year disease-free survival (DFS) for the entire population was 88% [77-94%]. The 3-year overall survival (OS) rate was 97% [88%-99%]. Microscopic vaginal resection margin (R1) was observed in one patient ([1].4%). Lymph-vascular space invasion (LVSI) was found found in 6 (8.6%) patients. Forty-eight late complications in 36 patients (51.4%) were observed. Five (7.1%) grade 3 vaginal wound dehiscence toxicities were observed. Urinary and gastrointestinal toxicities were grade 1-2. No grade 4-5 complications were observed. CONCLUSIONS: Preoperative image-guided adaptive brachytherapy followed by minimally invasive surgery allows high local control, reduces positive surgical margins and rates of lymph-vascular space invasion avoiding adjuvants treatments. Surgical approaches must be discussed with patients including preoperative brachytherapy as a down-staging treatment.
引用
- Varela Cagetti L, Gonzague-Casabianca L, Zemmour C, et al. The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer. Gynecol Oncol. 2021. PMID: 33563488. doi:10.1016/j.ygyno.2021.01.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。